{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T06:11:13Z","timestamp":1772259073436,"version":"3.50.1"},"reference-count":18,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2004,11,4]],"date-time":"2004-11-04T00:00:00Z","timestamp":1099526400000},"content-version":"vor","delay-in-days":2379,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Movement Disorders"],"published-print":{"date-parts":[[1998,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A retrospective study was carried out to investigate the evolution of patients diagnosed with cinnarizineinduced parkinsonism (CIP) over the past 15 years. A total of 74 cases of CIP were found among 172 patients with druginduced parkinsonism (DIP). Both CIP and other DIP were significantly more frequent in women. No clinical differences between CIP and other DIP were found. Most of the patients (66 of 74) completely recovered after cinnarizine withdrawal in 1\u201316 months. Eleven patients later developed Parkinson's disease; four of them had previously recovered. Five patients had tardive dyskinesia. CIP accounts for a high proportion of DIP referred to neurologists in populations in which cinnarizine is widely prescribed. The symptoms typically resolve after drug withdrawal, although complete recovery may take more than 1 year.<\/jats:p>","DOI":"10.1002\/mds.870130313","type":"journal-article","created":{"date-parts":[[2005,5,28]],"date-time":"2005-05-28T20:42:04Z","timestamp":1117312924000},"page":"453-456","source":"Crossref","is-referenced-by-count":60,"title":["Cinnarizine\u2010induced parkinsonism: Ten years later"],"prefix":"10.1002","volume":"13","author":[{"given":"Jos\u00e9 F.","family":"Mart\u00ed\u2010Mass\u00f3","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan J.","family":"Poza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,11,4]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870040205"},{"key":"e_1_2_1_3_2","first-page":"614","article-title":"Posible parkinsonismo inducido por cinaricina","volume":"85","author":"Mart\u00ed\u2010Mass\u00f3 JF","year":"1985","journal-title":"Medicina Cl\u00ednica (Barcelona)"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)92883-7"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199104000-00005"},{"key":"e_1_2_1_6_2","first-page":"5","article-title":"Cinaricina y enfermedad de Parkinson. Estudio doble ciego frente a placebo","volume":"1","author":"Mart\u00ed\u2010Mass\u00f3 JF.","year":"1986","journal-title":"Neurolog\u00eda"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199204000-00010"},{"key":"e_1_2_1_8_2","series-title":"4th International Symposium on Calcium Antagonist; Florence, Italy","first-page":"265","volume-title":"Effect of cinnarizine treatment on dopamine receptors in the brain of senescent BL c57\/J mice","author":"Camps M","year":"1989"},{"key":"e_1_2_1_9_2","unstructured":"ReirizJ.Estudio del funcionalismo dopamin\u00e9rgico en el cerebro de rata tras la administraci\u00f3n de f\u00e1rmacos antagonistas de los canales del calcio. Doctoral thesis Universidad de Barcelona 1991."},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(91)90526-V"},{"key":"e_1_2_1_11_2","first-page":"1221","article-title":"Effect of flunarizine hydrochloride on striatal D\u20102 dopamine receptors","volume":"30","author":"Ogawa N","year":"1990","journal-title":"Rinsho Shinkeigaku"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(91)90070-L"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(92)91112-R"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199202000-00003"},{"key":"e_1_2_1_15_2","first-page":"28","article-title":"Coexistence of severe parkinsonism and tardive dykinesia as side effects of neuroleptic therapy","volume":"45","author":"Bitton V","year":"1984","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-198712000-00002"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(91)90042-K"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)91223-7"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.118.543.171"}],"container-title":["Movement Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmds.870130313","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mds.870130313","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T14:47:48Z","timestamp":1760971668000},"score":1,"resource":{"primary":{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/10.1002\/mds.870130313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,5]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,5]]}},"alternative-id":["10.1002\/mds.870130313"],"URL":"https:\/\/doi.org\/10.1002\/mds.870130313","archive":["Portico"],"relation":{},"ISSN":["0885-3185","1531-8257"],"issn-type":[{"value":"0885-3185","type":"print"},{"value":"1531-8257","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,5]]}}}